Nuclear Medicine and Biology

Papers
(The TQCC of Nuclear Medicine and Biology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Radiofluorination of Sterically Hindered Amides: Automation, Stability Studies, and Mechanism77
[11C]HSP990 PET as a translational tool to investigate the aberrant role of Hsp90 in tumors and support the development of Hsp90 therapeutics49
Preclinical evaluation of [155/161Tb]Tb-crown-TATE – a novel SPECT imaging agent targeting neuroendocrine tumors46
Automated One-pot and One-step Radiosynthesis of [18F]VAT for PET Imaging of Vesicular Acetylcholine Transporter34
Development of a novel Azabenzimidazoles-Based PET radioligands for γ-8 dependent transmembrane AMPA receptor regulatory protein imaging32
Improving PET imaging of urothelial carcinoma using manual synthesis of [68Ga]Ga-FAPI-46 and automated synthesis of [18F]AlF-FAPI-7427
Longitudinal florzolotau (18F) PET study in a rat model of Alzheimer’s disease.25
Preclinical Evaluation of [18F]F-[natLu]Lu-DOTA-rhCCK-18, the First 18F-Labeled Radiohybrid-Based Minigastrin Derivative with high Target Affinity and Tumor Accumulation21
PEGylated liposome encapsulating nido-carborane: boron neutron capture therapy (BNCT) and in vivo trafficking study in animal models20
Indigenous preparation, quality control and evaluation of [90Y] Y-glass microspheres for treatment of liver cancer in India20
177Lu and 227Th Labeled 3,4,3-(LI-1,2-HOPO): characterization, optimized synthesis, biological distribution and dosimetry20
An orthogonal labeling strategy to accelerate bioconjugation of [99mTc]Tc-building blocks19
Versatile diphosphine platforms for molecular radio-pharmaceuticals based on technetium-99m and rhenium-18817
Synthesis of a porphyrin-PSMA conjugate and preliminary labelling with copper-6417
Chelator-based non-peptidic radiotracers for PET imaging of PD-L1 with copper-6415
Perspectives on nuclear chemistry, radiochemistry, PET/SPECT imaging and radiotherapy15
Copper-mediated 18F-fluorination of boroxines: a systematic optimization study15
Simple method for the production of [11C]phosgene15
Synthesis of [11C]Me-DPA and evaluation in transgenic mouse model of Alzheimer’s disease15
N-(4-[18F]fluorobenzyl)cholylglycine, a potential tracer for positron emission tomography of enterohepatic circulation and drug-induced inhibition of ileal bile acid transport. A proof-of-concept PET/14
Reduction of the hepatic radioactivity levels of [111In]In-DOTA–labeled antibodies via cleavage of a linkage metabolized in lysosomes14
Editorial Board14
Radiation dosimetry and efficacy of an 89Zr/225Ac-labeled humanized anti-MUC5AC antibody13
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information13
Radiolabeling yield dependency of post-dry distillation decay of astatine-21113
Retraction notice to “Radiosynthesis and biological evaluation of fluorine-18 labeled N-acetylgalactosamine derivative [18F]FPGalNAc for PET imaging of asialoglycoprotein receptor-positive tumors”. [N13
Evaluation of a bimodal, matched pair theranostic agent targeting prostate-specific membrane antigen12
[18F]FMISO-PET imaging reveals the role of hypoxia severity in checkpoint blockade response12
Status of radiobiology in molecular radionuclide therapy – Hope for the future12
New prospects for 89Zr-immuno-PET in brain applications – Alpha-synucleinopathies11
Preclinical evaluation of [68Ga]Ga-BCY18469, a first-in-class EphA2-targeting radiotheranostic Bicyclic Peptide11
Enhancing the accumulation level of 3-[18F]fluoro-L-α-methyltyrosine in tumors by preloading probenecid11
Study of activation cross sections of double neutron capture reaction on 193Ir for the reactor production route of radiotherapeutic 195mPt11
89Zr-immuno-PET guided preclinical development of targeted therapies: demonstrating utility by evaluating fusion proteins in vivo10
Mitochondria-targeted radiocomplexes for cancer theranostics10
The theranostic Goldilocks radionuclide copper-67 produced at a biomedical cyclotron10
Exploring the potential of high-specific activity samarium-153 for targeted radionuclide therapy with [153Sm]Sm-DOTA-TATE9
Editorial Board8
Targeting brain tumours with radiolabelled chlorotoxin, a scorpion venom peptide8
Non-invasive imaging of neutrophils in acute sepsis8
Introduction of terbium-161 into the clinics through its automated purification and the Good Manufacturing Practice compliant production of [161Tb]Tb-DOTA-LM38
Next generation copper complexes for efficient production of radiolabeled aromatics8
Development and radiolabelling of fluorinated ligands targetting the Aryl hydrocarbon Receptor8
[89Zr]ZrTrastuzumab automatic preparation on commercial cassette base synthesis module8
177LuIII- and 225AcIII-labelled bispidine-TATE conjugates: promising candidates for targeting neuroendocrine tumours8
[11C]Vercirnon - a candidate PET radioligand for the CCR9 chemokine receptor8
Translation of [68Ga]Ga-PSMA-11 radiosynthesis on the microfluidic system iMiDEVTM8
Characterization of a PET radioligand suitable for imaging and quantification of sigma-2 receptor in the primate brain7
What a difference an additional methylene makes: replacing Glu with Aad in the Lys-urea-Glu pharmacophore to reduce kidney and salivary gland uptake of PSMA-targeting radiopharmaceuticals7
Development and evaluation of new small molecule PET-radiotracers for the molecular imaging of inflammatory processes targeting S100A97
Site-selective 18F-labelling of octreotide via disulfide rebridging7
Evaluation of Affibody molecule Z09591 for PET imaging in fibrosis7
[68Ga]Ga-DOTA-C-glycosyl-RGD: synthesis, in vitro evaluation and PET imaging7
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information6
Synthesis and preclinical evaluation of [18F]AlF-NODA-MP-C6-CTHRSSVVC as a PET tracer for CD163-positive tumor-infiltrating macrophages6
Rhenium and technetium complexes in extremely low oxidation states6
Editorial Board6
Inorganic ion molar absorptivity at higher energy UV wavelengths and how it affects high performance liquid chromatography results6
Automated 18F-Al-radiolabelling optimization of PSMA-11 for PET imaging using a design of experiments approach6
Preclinical evaluation of MC1R targeting theranostic pair [155Tb]Tb-crown-αMSH and [161Tb]Tb-crown-αMSH6
Clinical grade [15O]O2 Production for Human Inhalation PET/MRI study6
Biodistribution of [18F]BCPP-BF in humans: a first-in-human positron emission tomography study6
Editorial Board5
Preparation and multimodality imaging study of 64Cu labeled organic nanoparticles targeting fibroblasts activation protein (FAP) in U87MG model5
Novel [124I]ATRi VE-821 analogue PET tracer in mouse models for prostate cancer5
Current developments in the production of actinium-225 from thorium-2295
Abstract withdrawn.5
Comparison of biodistribution according to administration route for the development of liposome therapeutics5
Radiosynthesis and evaluation of a new PET tracer for imaging of leucine-rich repeat kinase 25
Identifying Lymph Node Metastasis in High Grade Serous Ovarian Cancer Mouse Models via ImmunoPET Imaging5
[55Co]Co-DOTA-SP4: Towards NK1R-targeted Theranostics of Glioblastoma5
Preclinical evaluation of [111In]In-labeled GRPR-targeting DB15 mimics for potential theranostic use in prostate cancer5
Synthesis of novel PSMA ligands and preclinical evaluation of [99mTc]TcO-ABX474, a radioligand for SPECT imaging of prostate cancer5
Folate receptor targeted 64Cu/ICG-labeled layered double hydroxide nanoprobe for PET/CT and NIRF imaging5
Solid polyamine adsorbents for [11C]CO2 capture, purification, and radiosynthesis4
Brain energetics by biomedical modalities4
Title Page4
Synthesis/radiosynthesis and evaluation of three 18F radiotracers for imaging of sphingosine-1-phosphate receptor 14
Synthesis and biological evaluation of a novel radioligand [11C] BIO-1790735 for detection of O-GlcNAcase (OGA) enzyme activity4
Developing a Novel Microfluidics-based 86Y Purification Strategy for Rapid and Efficient Radiopharmaceutical Production4
Isotopic fluorine-18 radiolabelling of the anti-retroviral drug dolutegravir for pet imaging4
Access to 18F-labeled FAP inhibitor variants via [18F]SuFEx reaction4
GTP1 metabolic stability assessment: A study of the tau PET tracer [18F]GTP14
Automation of two-step one-vessel ditosylate synthon fluorination using Trasis AllinOne4
A decade of ubiquicidin development for PET imaging of infection: A systematic review4
Development of a highly hydrophilic 18F-tetrazine for pre-targeting approaches in PET imaging3
Correlation of hypoxia PET tracer uptake with hypoxic radioresistance in cancer cells: PET biomarkers of resistance to stereotactic radiation therapy?3
Development of small molecule PET-tracers targeting PD-L13
Trithiol ligand provides tumor-targeting 191Pt-complexes with high molar activity and promising in vivo properties3
Target occupancy studies of rho-associated protein kinase inhibitors in nonhuman primate with [11C]ROCK201 PET3
Radioactive Isotopes for Cancer Radiotherapy3
Synthesis and evaluation of PET ligands for monoacylglycerol lipase in brain3
Development of a PSMA Heterogeneous Tumor Model for Targeted Radiotherapy3
Radiolabeling of a polypeptide polymer for intratumoral delivery of alpha-particle emitter, 225Ac, and beta-particle emitter, 177Lu3
Evaluation of chelating agents based on pyridine-azacrown compounds H4PATA, PATAM, and H4PATPA for 68Ga and 177Lu3
Pretargeted PET imaging of trans-cyclooctene functionalized spherical nucleic acids3
Efficient chelation of 134Ce/La using the macrocyclic chelators DOTA and Macropa as potential PET imaging agents3
Low-dose targeted alpha therapy induces strong anti-tumor effectiveness in combination with immune checkpoint inhibitors3
Synthesis and evaluation of novel PET ligands for imaging Orexin2 receptor (OX2R)3
Discovery, synthesis and evaluation of novel reversible monoacylglycerol lipase radioligands bearing a morpholine-3-one scaffold3
A fluorescent probe as a lead compound for a selective α-synuclein PET tracer: development of a library of 2-styrylbenzothiazoles and biological evaluation of [18F]PFSB and [18F]MFSB3
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information3
Influence of the conjugation strategy on the stability of 89Zr-labeled immunoconjugates towards radiolysis2
Comparison of Evans Blue vs 4-(p-iodophenyl)butyric acid albumin binding moieties for lutetium-177-labeled LLP2A derivatives as theranostic agents for metastatic melanoma2
The Next Generation of Tumour Homing Peptides: Foldamers at the Forefront of Precise Cancer Theranostics2
The development of terbium-155 and terbium-161 towards radiotheragnostic clinical applications2
Chemokine receptor PET imaging: Bridging molecular insights with clinical applications2
Synthesis of a new 6-substituted 4-anilinoquinazoline derivative as irreversible inhibitor for EGFR imaging2
Quantitation of a CB1R tracer [18F]FPATPP with radioLC/MS/MS2
Investigations of terbium-161 towards prostate cancer therapy using albumin-binding and standard PSMA ligands2
Scale up production and purification of high specific activity lead-203 (203Pb)2
2,6-Bis-(N-hydroxylamino)-1,3,5-triazines as ligands for 45Ti-chelation2
8-Bicycloalkyl-CPFPX derivatives as potent and selective tools for PET imaging of the A1 adenosine receptor2
Rapid copper-mediated radiosynthesis optimization for a novel monoacylglycerol lipase PET tracer on a high-throughput microdroplet radiochemistry platform2
Quality assessment of cyclotron-produced 67Cu2
225Aс/213Bi generator for direct synthesis of 213Bi-labeled bioconjugates2
The importance of radiochemical purity: Cellular binding and internalization of different radiometal chlorides in prostate cancer cells2
Editorial Board2
In vitro and preliminary in vivo assessment of monocarboxylate transporter ligand as potential radiotracer for single photon emission computed tomography (SPECT) imaging of triple-negative breast canc2
Influence of radiolysis on astatine-211 chemistry2
Development of Astatine-211 labeling reaction using aryliodonium ylide2
Editorial Board2
Preparation of 5-[18F],7-difluoro- and 5,7-[18F]difluorotryptophans2
Development and validation of [18F]FDG dual radiosynthesis on a MX cassette with a NEPTIS® module2
Recovery and purification of Zn-68 after cyclotron irradiation and Ga-68 recovery2
Target manufacturing by Spark Plasma Sintering for efficient 89Zr production2
Preclinical evaluation of [11C]GW457427 as a tracer for neutrophil elastase2
Development of [18F]DASA-10 for enhanced imaging of pyruvate kinase M22
Development of a CCR2 targeted 18F-labeled radiotracer for atherosclerosis imaging with PET2
Clinical translation of the GRPR antagonist [99mTc]Tc-maSSS-PEG2-RM26 for targeting prostate tumors2
Synthesis and preclinical evaluation of 99mTc sandwich complexes targeting LAT1 and CRBN2
In vitro study of 177Lu-DOTA-Trastuzumab and 177Lu-DOTA-Pertuzumab for evaluation of binding affinity towards human cell lines with differential expression of HER-2 receptor2
Ultra-fast and efficient conversion of [11C]CO2 into [11C]hydantoins via the Bucherer-Bergs multicomponent reaction2
Studies of [89Zr]ZrDFO*-Labeled Human Serum Albumin Applying Different Cysteine Bioconjugation Chemistry2
Radiobioconjugates of 193m,195mPt nanoparticles for combined “chemo-Auger electron” therapy of hepatocellular carcinoma (HCC) and HER2+ breast and ovarian cancers2
Preparation and characterization and radiolabelling of multivalent ligands towards positron emission tomography imaging of oligomeric forms of misfolded proteins involved in neurodegenerative diseases1
Development of site-specifically labelled single-domain antibody PET probe for monitoring PD-L1 expression in cancer1
Next Generation of Radiopharmaceuticals via Engineering Antibody Derivatives1
Implementation and optimisation of scandium-44 and manganese-52 production at King’s College London for preclinical research1
Bispidin-9-ol derivatives for copper-64:67 radiolabeling and facile biofunctionalization strategies1
A facile synthesis of beta-amyloid PET imaging agent [18F]Florbetaben1
Evaluation of the combinationally glycated albumin nanoplatform for targeting the tumor microenvironment with minimized reticuloendothelial system uptake using PET imaging1
New CD8 imaging agents to evaluate T-cell infiltration in tumors and predict response to immunotherapy1
Separation of cyclotron-produced cobalt-55/58 m from iron targets using cation exchange chromatography1
Development of a stabilized GRPR antagonist for targeted cancer theranostics1
Synthesis of radiopharmaceuticals (At-AITM) for melanoma with overexpressed metabotropic glutamate receptor 11
Initial insights into the interaction of antibodies radiolabeled with Lutetium-177 and Actinium-225 with tumor microenvironment in experimental human and canine osteosarcoma1
Development of [68Ga]Ga-DOTA-4AH29, a radiolabeled single-domain antibody for PET imaging of FAP-α expression in cancer1
Evaluation of in vivo behavior of Na[F-18]F as a single substance and Na[F-18]F-contained mouthwashes via intra-trachea instillation1
HER2-specific Affibody Molecule [99mTc]Tc-ZHER2:41071: phase I clinical trial1
Radiosynthesis and evaluation of [18F]SNFT-1 for imaging early tau deposition1
In vivo validation of 68Ga-labeled AMD3100 conjugates for PET imaging of CXCR41
On the regiochemistry of the synthesis of 18F-labelled difluoroarenes via the copper mediated substitution of tin derivatives1
De novo design of lead structures for P2Y12 receptor tracer development using in silico methods1
Preclinical evaluation of [225Ac]Ac-crown-TATE – An alpha-emitting radiopharmaceutical for neuroendocrine tumors1
Automated radiosynthesis of meta-[18F]Fluorobenzylguanidine from a diaryliodonium salt precursor on NEPTIS® module1
PET/CT Imaging of avb6 Integrin to Monitor Radiation-Induced Pulmonary Fibrosis1
Laminated holmium-166-containing electrospun bandages for use against skin cancer1
Quantification of 89Zr-immunoPET: Methodological considerations1
Production of [18F]fluoromannitol facilitated by solid phase flow chemistry toward PET Imaging of bacterial Infections1
Radiolanthanum: Promising theranostic radionuclides for PET, alpha, and Auger-Meitner therapy1
Design, synthesis, and biological evaluation of orthosteric ligands for the muscarinic acetylcholine receptors1
Radiolabeling with [11C]HCN for Positron emission tomography1
Long term experience in [11C]UCB-J production in Turku PET Centre1
Radiosynthesis and biological investigation of an 18F-labeled triazolopyridopyrazine-based inhibitor for imaging of the phosphodiesterase 2A enzyme (PDE2A) in brain1
Utilizing click chemistry for PET infection imaging by fluorine-18 labeling of azide-modified bacteria1
ImmunoPET for mesothelin positive tissues using bio-orthogonal in-vivo click chemistry1
Albumin binders: a potential strategy for enhanced treatment of NETs using SSTR2 antagonists1
Borylation and 18F-Fluorination of arenes mediated by Lewis-acid organocatalysts1
Thiacrown Ligands for Encapsulation of Mercury-197 m/g into Radiopharmaceuticals1
Development of [64Cu]Cu-NGUL and [67Cu]Cu-NGUL as a matched-pair theranostic for prostate cancer1
Imaging and targeting S1PR1 in HER2+ tumors1
68Ga-: 99mTc-labeled LHRH analog as new potential breast cancer imaging agents1
Editorial Board1
Radiochemical aspects of synthesis and analysis of [177Lu]Lu-PSMA-617 and [177Lu]Lu-PSMA-I&T single-dose preparations1
cGMP synthesis of 4-[18F]fluoro-1-naphthol, a novel PET tracer for imaging activation of innate immunity1
Evaluation of [11C]HSP990 as a PET probe for in vivo visualisation of heat shock protein 90 in tumours1
[68Ga]Ga-DOTA-GIP1234 for PET imaging of glucose-dependent insulinotropic polypeptide receptor (GIPR)1
Synthesis, Dosimetry and Pharm/tox studies of MAO-B Analogue ([11C]COU) for Positron Emission Tomographic Studies1
Improving the quality of Ga radionuclides to achieve high radiolabeling yields1
Synthesis of a PSMA-targeting ligand with an optimized linker for imaging and treatment of prostate cancer1
Real-time tracking of micro- and nanoplastics in mice after pulmonary exposure1
Evaluation of tetramethylammonium salts in minimalist-like SNAr radiofluorinations1
Extracorporeal clearing traps based on tetrazine ligation for pretargeted therapy and diagnostics1
Radiosynthesis of 6-(2-cyclobutyl-5-(methyl-11C)-3H-imidazo[4,5-b]pyridin-3-yl)benzo[d]thiazol-2(3H)-one and (2-cyclobutyl-3-(1H-indazol-5-yl)-5-[11C]methyl-3H-imidazo[4,5-b]pyridine for imaging γ-8 d1
Corrigendum to “radiation dosimetry of the 18 kDa translocator protein ligand [18F]PBR111 in humans” [nuclear medicine and biology, 144–145 (2025); 109,011]1
Production, isolation, and shipment of clinically relevant quantities of astatine-211: A simple and efficient approach to increasing supply1
Synthesis and evaluation of an 18F-labeled PSMA-targeting tracer for imaging prostate cancer with positron emission tomography1
Choosing the right molar activity of an 122I-labeled irreversible inhibitor of transglutaminase 2 for quantitative expression profiling in tissues1
In-vitro binding assessment of soluble and insoluble tau protein variants with [18F]-AV1451 and [18F]-MK62401
NEw materials for conducting radiosynthesis of 18F-compounds1
Optimisation of the radiosynthesis of [18F]FDG on MX cassette: application to the dual batch process on NEPTIS® platform1
Development and in vitro evaluation of a copper-64 radiolabeled antibody for targeting the CXCR4 receptor in human multiple myeloma1
Peptide turn mimics formed by the coordination of Tc:Re-tricarbonyl1
Synthesis of PET tracers for imaging of thiocyanate efflux from the brain1
Identification and quantitative structure–activity relationship assessment of trace chemical impurities contained in the therapeutic formulation of [64Cu]Cu-ATSM1
Promising potential 68Ga-labeled small-molecular tracers for immune checkpoint ligand PD-L1 expression in tumor1
Comparison of 89Zr-Lumi804-IAB2MA and 89Zr-DFO-IAB2MA for PSMA-targeted PET Imaging of Prostate Cancer1
Development of a (+)RESCA-triaryl phosphine for in vitro radiolabeling using the Staudinger ligation1
CONTENTS1
Preclinical evaluation of 68Ga-labeled folic acid conjugates for visualization of inflammatory foci1
Myocardial kinetics of [11C]β-hydroxybutyrate in healthy pigs: Comparison of positron emission tomography imaging vs. arteriovenous balance methods1
Modification of a commercial radiochemistry module for facile cGMP production of [18F]FET and [18F]FSPG1
Biological evaluation of 111In-clickable complexes for cancer theranostics1
[18F]AlF and RESCA: a novel method for radiolabeling of Affibody molecules1
[89Zr]ZrCl4 for direct radiolabeling of DOTA-based precursors1
Conception of Nanoparticles as Diagnostic Agents1
Synthesis and evaluation of a 68Ga-labeled PSMA-targeting tracer with a rigid linker to reduce kidney and salivary gland uptake1
The development of [11C]M503-1619 as a PET tracer for imaging α-synucleinopathies in Parkinson’s disease (PD)1
Identifying new antigens on osteosarcoma and developing novel antibodies for radioimmunotherapy1
Practical considerations on the production of copper radioisotopes from enriched liquid targets: a five years’ experience1
Direct comparison of [18F]AlF-NOTA-JR11 and [18F]AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: Antagonist versus agonist1
Development and in vitro evaluation of new bifunctional 89Zr-chelators based on the 6-amino-1,4-diazepane scaffold for immuno-PET applications1
CycloSiFA - Towards the Next Generation of Silicon-Fluoride Acceptor based Positron Emission Tomography (PET) Imaging Probes1
Biologicals as theranostic vehicles in paediatric oncology1
Development of PSMA-targeted vectors containing an albumin binder and a cleavable linker1
Comparative evaluation of radiolabeled bombesin analogs [177Lu]Lu-AMBA and [177Lu]Lu-RM2 for targeting GRPR in glioblastoma model1
Preparation and preclinical evaluation of novel 18F-labeled FAP ligands0
Chelation of Manganese - 52 for development of long-lived PET radiopharmaceuticals0
Phase I trial for SPECT imaging of GRPR expression in malignant tumors using [99mTc]Tc-maSSS-PEG2-RM26 prepared using one-pot labeling kit0
Investigating the theranostic potential of a novel MUC16-targeted antibody for ovarian cancer0
[18F]FS-DPA: a novel PET probe for imaging of neuroinflammation easily accessible via SuFEx click labeling0
Automated purification of 18F-compounds by semi-preparative supercritical fluid chromatography (SFC)0
Antibody-based PET imaging of alpha-synuclein0
Analysis of radiochemical stability and in vivo distribution of recoiled 213Bi from [225Ac]Ac-DOTATATE in preclinical model0
Copper-free click labeling with the [99mTc]Tc-tricarbonyl-core using DACN derivatives0
Development and evaluaton of a trans-cyclooctene (TCO) probe for pretargeted PET imaging0
Development of a 99mTc-NTP 15-5 kit for an early clinical trial0
Synthesis and evaluation of a [68Ga]Ga-labeled water soluble porphyrin as a tumor targeting theranostic agent: in-vitro and in-vivo studies0
Evaluation of lysine modifications in the PSMA-targeting pharmacophore using positron emission tomography imaging in a preclinical model of human prostate cancer0
A novel tetrahydrothienopyridine-based PET tracer for P2Y12 receptor imaging in the brain0
Bifunctional [2.2.2]-cryptands: Selective and efficient chelators for the 203Pb/212Pb theranostic pair0
A Novel Purification Method to Improve the Chemical Purity of the 203Pb/212Pb Theranostic Pair0
[18F]SuFEx-enabled access to an 18F-Labeled PSMA inhibitor intermediate0
Evaluation of PET-based Human Biodistribution of a Novel Amino Acid 11C-MeLeu PET/CT Imaging in Normal Volunteers0
Radiosynthesis, in vitro and in vivo evaluation of [18F]Z-3540 for imaging 4R-tauopathies0
Synthesis, characterization and biodistribution of a new ‘2+1’ 99mTc/Re tricarbonyl complex bearing bis(2-hydroxyethyl) carbamodithioate and 4-anilinoquinazoline derivative0
Radiolabeling and evaluation of 68Ga-DOTA-F56 peptide targeting vascular endothelial growth factor receptor0
Synthesis and radiolabeling of [11C]CP31398 and fluorine-18 derivatives for PET imaging targeting p530
64Cu-labeled fucoidan nanoparticles for non-invasive PET/CT tumor imaging0
A 177Lu-labeled anti-HER2 dual variable domain antibody0
Synthesis and evaluation of a novel PET tracer for imaging monoamine oxidase-B0
Immune mediated inflammation and perfusion in lungs of Covid-19 patients studied with [11C]GW457427 and [15O]water: a first-in-man pilot study0
Development of gallium coordinate nonapeptides as candidates for PET imaging of neuropeptide Y1 receptors in oncology0
Structure-activity relationship of pyrazol-4-yl-pyridine derivatives for imaging the muscarinic acetylcholine receptor M40
Investigation into metabolic profile of [11C]Me-DPA0
Evaluating the in vivo distribution and stability of a 161Tb-labeled nanobody for potential cancer therapy0
Fully automated radiochemical synthesis of [68Ga]FAPI-4 and its preclinical evaluation for clinical translation0
Development and pre-clinical evaluation of new 64Cu-NOTA-folate conjugates for PET imaging of folate receptor-positive tumors0
Tumor stroma diagnostic imaging by a 68Ga-coupled small-molecule fibroblast activation protein (FAP) inhibitor: first pre-clinical data0
0.13849115371704